Thanks Goines, for those kind words: I also went through the R/S but made out okay in the end. I can’t see the motivation why he would sell [any significant portion] of his shares at such a low price.
Especially since we are on the cusp of initiation and data in regards to 2 possibly 3 Phase 11 trials within 6 month’s as RK has so eloquently mentioned in her posts.
I believe that he has sold some shares here along the way in line with other institutions that got cheap warrants, thus the pressure on the stock to this point.
Having said that would rather have them all sell portions down here then get hit hard when the really good news comes along [eg Phase 11 initiation, recurrence, partnership BP.
I can’t find any other reason that there has been so much pressure on the stock MM manipulation I don’t believe would be that prevalent for this long.
Like others have mentioned Dart seems to hold great companies...and Tapimmune is shaping up to be just that.
Patience I once again we reiterate that I think we are on the verge on making everyone believers, remember that Tapimmunes technology is unprecedented. In the fact that they have a simple low cost, non toxic product, unlike others that have to take cells out manipulate them then reintroduce the cells back into the body...”VERY EXPENSIVE”.
Hillary’s comments may have hurt the Bio tech sector in the short term, but for us down the road it is great because BP must look for technologies that are much more cost effective.
Enjoy the ride believe you have made a great investment choice.
BLU
News 
Market Data 
Discover 
AI
